Related Experiment Videos

Transcutaneous oxygen monitoring and retinopathy of prematurity

E Bancalari1, J Flynn, R N Goldberg

  • 1Dept. of Pediatrics, University of Miami/School of Medicine, Florida 33101.

Insights

Continuous transcutaneous oxygen monitoring (tcPO2) may reduce retinopathy of prematurity (ROP) in preterm infants over 1000 grams. However, it did not significantly impact ROP incidence in smaller infants.

Area of Science:

  • Neonatalogy
  • Pediatric Ophthalmology
  • Critical Care Medicine

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in preterm infants.
  • Oxygen therapy is crucial for preterm infants but carries risks for ROP development.
  • Current monitoring practices for oxygenation vary, impacting ROP outcomes.

Purpose of the Study:

  • To investigate if continuous transcutaneous oxygen monitoring (tcPO2) reduces ROP incidence in preterm infants receiving oxygen therapy.
  • To compare ROP rates between continuous monitoring and standard care groups.

Main Methods:

  • A randomized controlled trial involving 296 preterm infants (birth weight ≤ 1300 grams).
  • Infants were assigned to either continuous tcPO2 monitoring (CM) or standard care (SC) groups.
  • tcPO2 was monitored continuously in the CM group and intermittently in the SC group during acute illness.

Main Results:

  • Overall ROP incidence was 51% in the CM group and 59% in the SC group.
  • Continuous tcPO2 monitoring showed a potential reduction in ROP for infants >1000g birth weight.
  • No significant difference in ROP incidence was observed for infants <1000g birth weight.

Conclusions:

  • Continuous tcPO2 monitoring may be beneficial in reducing ROP in larger preterm infants (>1000g).
  • Smaller preterm infants (<1000g) with higher ROP risk and severity may not benefit from this monitoring strategy.
  • Further research is needed to optimize oxygen management for high-risk preterm infants.

Related Concept Videos